Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence
- PMID: 27838724
- PMCID: PMC5429025
- DOI: 10.1001/jama.2016.15212
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence
Conflict of interest statement
Comment in
-
Use of Statins in Adults Older Than 75 Years.JAMA. 2017 Mar 14;317(10):1081. doi: 10.1001/jama.2017.0382. JAMA. 2017. PMID: 28291887 No abstract available.
Similar articles
-
Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.Med Clin North Am. 2017 Jul;101(4):689-699. doi: 10.1016/j.mcna.2017.03.001. Med Clin North Am. 2017. PMID: 28577620 Review.
-
Statins for primary prevention in older adults.Ann Intern Med. 2015 Apr 21;162(8):I-28. doi: 10.7326/P15-9012. Ann Intern Med. 2015. PMID: 25894041 No abstract available.
-
Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011. Epub 2014 Mar 7. Arch Cardiovasc Dis. 2014. PMID: 24613429
-
Statin therapy for primary prevention of cardiovascular disease.JAMA. 2013 Dec 11;310(22):2451-2. doi: 10.1001/jama.2013.281348. JAMA. 2013. PMID: 24276813
-
Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.Am J Geriatr Pharmacother. 2007 Mar;5(1):52-63. doi: 10.1016/j.amjopharm.2007.03.008. Am J Geriatr Pharmacother. 2007. PMID: 17608248 Review.
Cited by
-
Is LDL cholesterol associated with long-term mortality among primary prevention adults? A retrospective cohort study from a large healthcare system.BMJ Open. 2024 Mar 28;14(3):e077949. doi: 10.1136/bmjopen-2023-077949. BMJ Open. 2024. PMID: 38548371 Free PMC article.
-
Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.JAMA Netw Open. 2023 Dec 1;6(12):e2346373. doi: 10.1001/jamanetworkopen.2023.46373. JAMA Netw Open. 2023. PMID: 38055276 Free PMC article. Clinical Trial.
-
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.J Gerontol A Biol Sci Med Sci. 2024 Feb 1;79(2):glad181. doi: 10.1093/gerona/glad181. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37527836 Free PMC article. Clinical Trial.
-
Performance of Cox regression models for composite time-to-event endpoints with component-wise censoring in randomized trials.Clin Trials. 2023 Oct;20(5):507-516. doi: 10.1177/17407745231177046. Epub 2023 May 26. Clin Trials. 2023. PMID: 37243355 Free PMC article.
-
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale.J Am Geriatr Soc. 2023 Jun;71(6):1701-1713. doi: 10.1111/jgs.18312. Epub 2023 Apr 20. J Am Geriatr Soc. 2023. PMID: 37082807 Free PMC article. Clinical Trial.
References
-
- Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1–S45. - PubMed
-
- Shepherd J, Blauw GJ, Murphy MB, et al. PROSPER Study Group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–1630. - PubMed
-
- Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152(8):488–496. - PMC - PubMed
-
- Yusuf S, Bosch J, Dagenais G, et al. HOPE-3 Investigators. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2021–2031. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical